Y-mAbs Therapeutics Inc
NASDAQ:YMAB
Cash Flow Statement
Cash Flow Statement
Y-mAbs Therapeutics Inc
Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow | |||||||||||||||||||||||||
Net Income |
(27)
|
(31)
|
(38)
|
(43)
|
(52)
|
(59)
|
(72)
|
(81)
|
(91)
|
(114)
|
(123)
|
(119)
|
(60)
|
(42)
|
(38)
|
(55)
|
(117)
|
(135)
|
(134)
|
(96)
|
(74)
|
(39)
|
(19)
|
(21)
|
|
Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
Stock-Based Compensation |
1
|
2
|
2
|
2
|
3
|
3
|
4
|
5
|
6
|
7
|
9
|
16
|
19
|
21
|
23
|
19
|
20
|
29
|
27
|
26
|
26
|
16
|
15
|
0
|
|
Other Non-Cash Items |
1
|
1
|
2
|
2
|
3
|
3
|
4
|
5
|
6
|
16
|
18
|
24
|
(35)
|
(41)
|
(39)
|
(41)
|
22
|
32
|
32
|
29
|
29
|
17
|
14
|
13
|
|
Cash Taxes Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Change in Working Capital |
3
|
2
|
3
|
(0)
|
1
|
6
|
6
|
3
|
3
|
2
|
6
|
3
|
(7)
|
(10)
|
(10)
|
(7)
|
(1)
|
3
|
(0)
|
(10)
|
(20)
|
(24)
|
(24)
|
(20)
|
|
Cash from Operating Activities |
(22)
N/A
|
(27)
-22%
|
(34)
-24%
|
(41)
-21%
|
(48)
-17%
|
(50)
-5%
|
(63)
-24%
|
(74)
-18%
|
(82)
-11%
|
(95)
-17%
|
(98)
-3%
|
(91)
+7%
|
(101)
-11%
|
(92)
+9%
|
(86)
+7%
|
(103)
-19%
|
(96)
+7%
|
(100)
-5%
|
(101)
-1%
|
(76)
+25%
|
(64)
+16%
|
(46)
+29%
|
(28)
+39%
|
(27)
+2%
|
|
Investing Cash Flow | |||||||||||||||||||||||||
Capital Expenditures |
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(2)
|
(2)
|
(2)
|
(1)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
|
Other Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(3)
|
(3)
|
59
|
59
|
62
|
62
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Cash from Investing Activities |
0
N/A
|
(0)
N/A
|
(0)
-50%
|
(0)
-28%
|
(0)
-57%
|
(0)
+14%
|
(1)
-181%
|
(2)
-126%
|
(2)
+5%
|
(2)
+4%
|
(4)
-116%
|
(3)
+28%
|
59
N/A
|
59
0%
|
61
+4%
|
61
-1%
|
(1)
N/A
|
(1)
+7%
|
(0)
+13%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
Financing Cash Flow | |||||||||||||||||||||||||
Net Issuance of Common Stock |
0
|
79
|
167
|
100
|
0
|
0
|
(2)
|
135
|
135
|
135
|
135
|
2
|
109
|
110
|
110
|
108
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other |
(2)
|
(1)
|
(1)
|
(1)
|
1
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Cash from Financing Activities |
88
N/A
|
78
-12%
|
166
+113%
|
99
-40%
|
100
+2%
|
101
+0%
|
(2)
N/A
|
135
N/A
|
135
+0%
|
135
N/A
|
135
+0%
|
2
-99%
|
109
+5 374%
|
110
+0%
|
110
+0%
|
108
-1%
|
1
-100%
|
0
-26%
|
0
-51%
|
0
-56%
|
0
-38%
|
0
N/A
|
0
N/A
|
0
N/A
|
|
Change in Cash | |||||||||||||||||||||||||
Effect of Foreign Exchange Rates |
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
0
|
|
Net Change in Cash |
65
N/A
|
50
-23%
|
132
+163%
|
57
-56%
|
52
-9%
|
50
-4%
|
(65)
N/A
|
59
N/A
|
51
-13%
|
38
-26%
|
33
-13%
|
(93)
N/A
|
67
N/A
|
76
+14%
|
84
+12%
|
67
-21%
|
(96)
N/A
|
(100)
-5%
|
(101)
-1%
|
(76)
+25%
|
(64)
+15%
|
(46)
+29%
|
(28)
+39%
|
(27)
+3%
|
|
Free Cash Flow | |||||||||||||||||||||||||
Free Cash Flow |
(22)
N/A
|
(28)
-23%
|
(34)
-24%
|
(41)
-21%
|
(48)
-17%
|
(51)
-4%
|
(63)
-25%
|
(75)
-19%
|
(84)
-11%
|
(97)
-16%
|
(99)
-2%
|
(91)
+8%
|
(102)
-11%
|
(93)
+9%
|
(87)
+7%
|
(104)
-19%
|
(96)
+7%
|
(101)
-4%
|
(102)
-1%
|
(76)
+25%
|
(64)
+16%
|
(46)
+29%
|
(28)
+39%
|
(27)
+2%
|